Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Melatonin receptor structure solved

May 3, 2019

NIH to send 3-D tissue chips into space to study aging and diseases accelerated in microgravity

April 26, 2019

Emendo Biotherapeutics signs licensing agreement with Takeda Pharmaceutical for OMNI nuclear program

April 25, 2019

Using promiscuity to identify high-commitment targets

April 16, 2019

NapaJen, Astellas enter collaboration for development of novel oligonucleotides

March 21, 2019

Alexion and Zealand Pharma collaborate to discover and develop novel peptide therapies

March 21, 2019

New chemogenetics system could find clinical use

March 20, 2019

New method greenlights Myc targeting

March 18, 2019

Hitgen, Sun Pharma Advanced Research enter DEL-based drug discovery collaboration

March 14, 2019

Adagene announces platform evaluation with Celgene

March 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Capital remains selective in ‘barbell’ biotech market
BioWorld Asia
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...